Speaker illustration

Doctor Mi Joo Kim

Daejeon ()

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Event: ESC CONGRESS 2016

Topic: Thrombosis and platelets

Session: Antiplatelet therapy

Thumbnail

This platform is supported by

logo Novo Nordisk